Merck | MRK - Capitaux D'Emprunt

Prix De L'Action
110.04
Variation Quotidienne
-0.19 -0.17%
Mensuellement
-6.82%
Annuel
29.90%
Q2 Prévisions
109.51




Capitaux D'Emprunt Changement Date
AbbVie USD 62.97B 12M 2025-09
Abbott USD 9.9B 1.7B 2025-12
ALKERMES USD 285.82M 639K 2024-09
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Biogen USD 6.29B 1.4M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Coherus Biosciences USD 51.08M 496K 2025-12
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.13B 6M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
Glaxosmithkline GBP 19.82B 203.13M 2025-12
J&J USD 37.53B 1.91B 2026-03
Medtronic USD 27.88B 255M 2025-12
Merck USD 39.97B 6B 2025-09
Novartis USD 29.59B 5.35B 2025-12
Novartis USD 29.59B 5.35B 2025-12
Novo Nordisk DKK 118.94B 29.76B 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 13.84B 1.88B 2026-03
Sanofi EUR 15.72B 150.06M 2025-12
United Therapeutics USD 100M 100M 2024-06
Zoetis USD 9.04B 1.97B 2025-12